Integral Health Asset Management’s Zai Lab ZLAB Stock Holding History

Integral Health Asset Management’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-156,554	Closed	-$5.43M	–	80
2022 Q2	$5.43M	Buy	156,554 +81,554	+109%	+$2.88M	1.12%	33
2022 Q1	$3.3M	Buy	+75,000	New	+$3.63M	0.86%	41
2021 Q3	–	Sell	-25,000	Closed	-$4.42M	–	88
2021 Q2	$4.42M	Sell	25,000 -20,000	-44%	-$3.22M	1.22%	33
2021 Q1	$6M	Buy	45,000 +15,000	+50%	+$2.32M	1.72%	20
2020 Q4	$4.06M	Buy	30,000 +5,000	+20%	+$509K	1.21%	31
2020 Q3	$2.08M	Buy	+25,000	New	+$2.01M	0.64%	54

Other funds holding ZLAB

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Integral Health Asset Management's ZLAB Position: Q3 2022 in Review

Integral Health Asset Management sold out of Zai Lab (ZLAB) in Q3 2022, closing a stake of 156,554 shares — an estimated $5.43M sold.

Integral Health Asset Management first reported a position in ZLAB in Q3 2020 and held it in 6 quarters. The position peaked at $6M in Q1 2021. 170 funds tracked by Wall St. Rank hold ZLAB as of Q3 2022.

Integral Health Asset Management reported no remaining Zai Lab position as of Q3 2022 after selling out during the quarter.
Integral Health Asset Management sold 156,554 Zai Lab shares in Q3 2022, an estimated $5.43M.
Integral Health Asset Management first reported a position in Zai Lab in Q3 2020 and held it in 6 quarters.
Integral Health Asset Management's Zai Lab position peaked at $6M in Q1 2021.
170 funds tracked by Wall St. Rank held Zai Lab as of Q3 2022.

Based on Integral Health Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.